Nexon Co., Ltd. will grant 2,749,912 stock-based stock options to directors free of charge, with the allocation date set for April 10, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3659","jir_company_name":"Nexon Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-03-25","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/03\/3659-20260325-02.pdf","jir_short_summary":"Nexon Co., Ltd. will grant 2,749,912 stock-based stock options to directors free of charge, with the allocation date set for April 10, 2026.","jir_summary":"### Overview of Stock Option Issuance\nAt the board meeting on March 25, 2026, Nexon Co., Ltd. resolved to issue the 30th stock options (share acquisition rights) to directors (excluding directors who are audit committee members). The total number of share acquisition rights issued is 2,749,912 units, of which 12,541 units are allocated to outside directors. The share acquisition rights are granted free of charge, and the exercise period is ten years from the allocation date. An exercise condition requires the director to hold the position at the time of exercise, but exercise is allowed under certain conditions even after resignation.\n\n### Impact on Shareholders and Capital and Other Conditions\nThe number of shares issued upon exercise of the share acquisition rights will be 2,749,912 shares. Adjustments to the number of shares will be made within a reasonable scope in the event of stock splits, reverse splits, or corporate reorganizations. Transfer of the share acquisition rights requires board approval, and no payment is required at the time of exercise. Calculation methods for the increased capital and capital surplus are also specified. The allocation date is April 10, 2026.","jir_financial_highlights":"Number of Share Acquisition Rights: 2,749,912 units (Unknown)\nNumber of Allottees: 2 directors (including 1 outside director) (Unknown)\nAllocation Date: 2026-04-10 (Unknown)","jir_category":"","jir_hashtags":"#NexonCoLtd, #StockOptions, #IR","jir_key_figures":"Number of Share Acquisition Rights Issued: 2,749,912 units\nNumber of Allotted Directors: 2 (including 1 outside director)\nAllocation Date: 2026-04-10","jir_meta_title":"Nexon Co., Ltd. Decides to Grant 2,749,912 Stock Options to Directors as 30th Issuance","jir_meta_description":"Nexon Co., Ltd. announced the free grant of 2,749,912 stock-based stock options to directors effective April 10, 2026. The exercise period is ten years.","jir_og_title":"Nexon Co., Ltd. Announces Grant of 30th Stock Options","jir_og_description":"Free grant of 2,749,912 share acquisition rights to directors. Allocation date is April 10, 2026, with an exercise period of ten years.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":6922,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-36549","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n